<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34586891</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>22</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1098-660X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>60</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of clinical microbiology</Title>
          <ISOAbbreviation>J Clin Microbiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Current Developments in Diagnostic Assays for Laboratory Confirmation and Investigation of Botulism.</ArticleTitle>
        <Pagination>
          <StartPage>e0013920</StartPage>
          <MedlinePgn>e0013920</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">e00139-20</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1128/JCM.00139-20</ELocationID>
        <Abstract>
          <AbstractText>Detection of botulinum neurotoxin or isolation of the toxin-producing organism is required for the laboratory confirmation of botulism in clinical specimens. In an effort to reduce animal testing required by the gold standard method of botulinum neurotoxin detection, the mouse bioassay, many technologies have been developed to detect and characterize the causative agent of botulism. Recent advancements in these technologies have led to improvements in technical performance of diagnostic assays; however, many emerging assays have not been validated for the detection of all serotypes in complex clinical and environmental matrices. Improvements to culture protocols, endopeptidase-based assays, and a variety of immunological and molecular methods have provided laboratories with a variety of testing options to evaluate and incorporate into their testing algorithms. While significant advances have been made to improve these assays, additional work is necessary to evaluate these methods in various clinical matrices and to establish standardized criteria for data analysis and interpretation.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Centurioni</LastName>
            <ForeName>Dominick A</ForeName>
            <Initials>DA</Initials>
            <Identifier Source="ORCID">0000-0001-9530-6288</Identifier>
            <AffiliationInfo>
              <Affiliation>Wadsworth Center, New York State Department of Health, Albany, New York, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Egan</LastName>
            <ForeName>Christina T</ForeName>
            <Initials>CT</Initials>
            <AffiliationInfo>
              <Affiliation>Wadsworth Center, New York State Department of Health, Albany, New York, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Perry</LastName>
            <ForeName>Michael J</ForeName>
            <Initials>MJ</Initials>
            <AffiliationInfo>
              <Affiliation>Wadsworth Center, New York State Department of Health, Albany, New York, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>09</Month>
          <Day>29</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Clin Microbiol</MedlineTA>
        <NlmUniqueID>7505564</NlmUniqueID>
        <ISSNLinking>0095-1137</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>EC 3.4.24.69</RegistryNumber>
          <NameOfSubstance UI="D001905">Botulinum Toxins</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001681" MajorTopicYN="N">Biological Assay</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001905" MajorTopicYN="Y">Botulinum Toxins</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001906" MajorTopicYN="Y">Botulism</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003014" MajorTopicYN="Y">Clostridium botulinum</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007753" MajorTopicYN="N">Laboratories</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D065288" MajorTopicYN="N">Serogroup</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Clostridium botulinum</Keyword>
        <Keyword MajorTopicYN="Y">Endopep-MS</Keyword>
        <Keyword MajorTopicYN="Y">botulinum neurotoxin</Keyword>
        <Keyword MajorTopicYN="Y">botulism</Keyword>
        <Keyword MajorTopicYN="Y">diagnostic assay</Keyword>
        <Keyword MajorTopicYN="Y">toxins</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2022</Year>
          <Month>9</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>29</Day>
          <Hour>17</Hour>
          <Minute>13</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34586891</ArticleId>
        <ArticleId IdType="pmc">PMC9020338</ArticleId>
        <ArticleId IdType="doi">10.1128/JCM.00139-20</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Humeau Y, Doussau F, Grant NJ, Poulain B. 2000. How botulinum and tetanus neurotoxins block neurotransmitter release. Biochimie
82:427–446. 10.1016/S0300-9084(00)00216-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0300-9084(00)00216-9</ArticleId>
            <ArticleId IdType="pubmed">10865130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, Lillibridge S, Osterholm MT, O’Toole T, Parker G, Perl TM, Russell PK, Swerdlow DL, Tonat K, Working Group on Civilian Biodefense. 2001. Botulinum toxin as a biological weapon: medical and public health management. JAMA
285:1059–1070. 10.1001/jama.285.8.1059.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.285.8.1059</ArticleId>
            <ArticleId IdType="pubmed">11209178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dembek ZF, Smith LA, Rusnak JM. 2007. Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities. Disaster Med Public Health Prep
1:122–134. 10.1097/DMP.0b013e318158c5fd.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/DMP.0b013e318158c5fd</ArticleId>
            <ArticleId IdType="pubmed">18388640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rao AK, Sobel J, Chatham-Stephens K, Luquez C. 2021. Clinical guidelines for diagnosis and treatment of botulism, 2021. MMWR Recomm Rep
70:1–30. 10.15585/mmwr.rr7002a1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.15585/mmwr.rr7002a1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lamanna C. 1959. The most poisonous poison. Science
130:763–772. 10.1126/science.130.3378.763.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.130.3378.763</ArticleId>
            <ArticleId IdType="pubmed">14413547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rossetto O, Pirazzini M, Montecucco C. 2014. Botulinum neurotoxins: genetic, structural and mechanistic insights. Nat Rev Microbiol
12:535–549. 10.1038/nrmicro3295.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrmicro3295</ArticleId>
            <ArticleId IdType="pubmed">24975322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dong M, Stenmark P. 2021. The structure and classification of botulinum toxins, p 11–33. In
Whitcup SM, Hallett M (ed), Botulinum toxin therapy.
Springer International Publishing, Cham, Switzerland.</Citation>
        </Reference>
        <Reference>
          <Citation>Peck MW, Smith TJ, Anniballi F, Austin JW, Bano L, Bradshaw M, Cuervo P, Cheng LW, Derman Y, Dorner BG, Fisher A, Hill KK, Kalb SR, Korkeala H, Lindstrom M, Lista F, Luquez C, Mazuet C, Pirazzini M, Popoff MR, Rossetto O, Rummel A, Sesardic D, Singh BR, Stringer SC. 2017. Historical perspectives and guidelines for botulinum neurotoxin subtype nomenclature. Toxins (Basel
9) :38. 10.3390/toxins9010038.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/toxins9010038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hill KK, Xie G, Foley BT, Smith TJ. 2015. Genetic diversity within the botulinum neurotoxin-producing bacteria and their neurotoxins. Toxicon
107:2–8. 10.1016/j.toxicon.2015.09.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.toxicon.2015.09.011</ArticleId>
            <ArticleId IdType="pubmed">26368006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith T, Williamson CHD, Hill K, Sahl J, Keim P. 2018. Botulinum neurotoxin-producing bacteria. Isn’t it time that we called a species a species?
mBio
9:e01469-18. 10.1128/mBio.01469-18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.01469-18</ArticleId>
            <ArticleId IdType="pmc">PMC6156192</ArticleId>
            <ArticleId IdType="pubmed">30254123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maslanka SE, Lúquez C, Dykes JK, Tepp WH, Pier CL, Pellett S, Raphael BH, Kalb SR, Barr JR, Rao A, Johnson EA. 2016. A novel botulinum neurotoxin, previously reported as serotype H, has a hybrid-like structure with regions of similarity to the structures of serotypes A and F and is neutralized with serotype A antitoxin. J Infect Dis
213:379–385. 10.1093/infdis/jiv327.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jiv327</ArticleId>
            <ArticleId IdType="pmc">PMC4704661</ArticleId>
            <ArticleId IdType="pubmed">26068781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hutson RA, Zhou Y, Collins MD, Johnson EA, Hatheway CL, Sugiyama H. 1996. Genetic characterization of Clostridium botulinum type A containing silent type B neurotoxin gene sequences. J Biol Chem
271:10786–10792. 10.1074/jbc.271.18.10786.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.271.18.10786</ArticleId>
            <ArticleId IdType="pubmed">8631890</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mansfield MJ, Adams JB, Doxey AC. 2015. Botulinum neurotoxin homologs in non-Clostridium species. FEBS Lett
589:342–348. 10.1016/j.febslet.2014.12.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.febslet.2014.12.018</ArticleId>
            <ArticleId IdType="pubmed">25541486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wentz TG, Muruvanda T, Lomonaco S, Thirunavukkarasu N, Hoffmann M, Allard MW, Hodge DR, Pillai SP, Hammack TS, Brown EW, Sharma SK. 2017. Closed genome sequence of Chryseobacterium piperi strain CTM(T)/ATCC BAA-1782, a Gram-negative bacterium with clostridial neurotoxin-like coding sequences. Genome Announc
5:e01296-17. 10.1128/genomeA.01296-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/genomeA.01296-17</ArticleId>
            <ArticleId IdType="pmc">PMC5722062</ArticleId>
            <ArticleId IdType="pubmed">29192076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brunt J, Carter AT, Stringer SC, Peck MW. 2018. Identification of a novel botulinum neurotoxin gene cluster in Enterococcus. FEBS Lett
592:310–317. 10.1002/1873-3468.12969.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/1873-3468.12969</ArticleId>
            <ArticleId IdType="pmc">PMC5838542</ArticleId>
            <ArticleId IdType="pubmed">29323697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zornetta I, Azarnia Tehran D, Arrigoni G, Anniballi F, Bano L, Leka O, Zanotti G, Binz T, Montecucco C. 2016. The first non clostridial botulinum-like toxin cleaves VAMP within the juxtamembrane domain. Sci Rep
6:30257. 10.1038/srep30257.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep30257</ArticleId>
            <ArticleId IdType="pmc">PMC4957215</ArticleId>
            <ArticleId IdType="pubmed">27443638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rasetti-Escargueil C, Lemichez E, Popoff MR. 2019. Public health risk associated with botulism as foodborne zoonoses. Toxins
12:17. 10.3390/toxins12010017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/toxins12010017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sonnabend O, Sonnabend W, Heinzle R, Sigrist T, Dirnhofer R, Krech U. 1981. Isolation of Clostridium botulinum type G and identification of type G botulinal toxin in humans: report of five sudden unexpected deaths. J Infect Dis
143:22–27. 10.1093/infdis/143.1.22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/143.1.22</ArticleId>
            <ArticleId IdType="pubmed">7012244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lindström M, Korkeala H. 2006. Laboratory diagnostics of botulism. Clin Microbiol Rev
19:298–314. 10.1128/CMR.19.2.298-314.2006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.19.2.298-314.2006</ArticleId>
            <ArticleId IdType="pmc">PMC1471988</ArticleId>
            <ArticleId IdType="pubmed">16614251</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meechan PJ, Potts J. 2020. Biosafety in microbiological and biomedical laboratories.
U.S. Department of Health and Human Services, Washington, DC.</Citation>
        </Reference>
        <Reference>
          <Citation>Woodruff BA, Griffin PM, McCroskey LM, Smart JF, Wainwright RB, Bryant RG, Hutwagner LC, Hatheway CL. 1992. Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, 1975–1988. J Infect Dis
166:1281–1286. 10.1093/infdis/166.6.1281.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/166.6.1281</ArticleId>
            <ArticleId IdType="pubmed">1431246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>National Center for Infectious Diseases (U.S.). Division of Bacterial and Mycotic Diseases. 1998. Botulism in the United States, 1899–1996.
U.S. Dept. of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, Atlanta, GA.</Citation>
        </Reference>
        <Reference>
          <Citation>Oikarinen S, Tauriainen S, Viskari H, Simell O, Knip M, Virtanen S, Hyöty H. 2009. PCR inhibition in stool samples in relation to age of infants. J Clin Virol
44:211–214. 10.1016/j.jcv.2008.12.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcv.2008.12.017</ArticleId>
            <ArticleId IdType="pubmed">19196549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lúquez C, Edwards L, Griffin C, Sobel J. 2021. Foodborne botulism outbreaks in the United States, 2001–2017. Front Microbiol
10.3389/fmicb.2021.713101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2021.713101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nevas M, Lindström M, Virtanen A, Hielm S, Kuusi M, Arnon SS, Vuori E, Korkeala H. 2005. Infant botulism acquired from household dust presenting as sudden infant death syndrome. J Clin Microbiol
43:511–513. 10.1128/JCM.43.1.511-513.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.43.1.511-513.2005</ArticleId>
            <ArticleId IdType="pmc">PMC540168</ArticleId>
            <ArticleId IdType="pubmed">15635031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koepke R, Sobel J, Arnon SS. 2008. Global occurrence of infant botulism, 1976–2006. Pediatrics
122:e73–e82. 10.1542/peds.2007-1827.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/peds.2007-1827</ArticleId>
            <ArticleId IdType="pubmed">18595978</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bergeron G, Latash J, Costa-Carter C-AD, Egan C, Stavinsky F, Kileci JA, Winstead A, Zhao B, Perry MJ, Chatham-Stephens K, Sarpel D, Hughes S, Conlon MA, Edmunds S, Mohanraj M, Rakeman JL, Centurioni DA, Lúquez C, Chiefari AK, Harper S. 2019. Botulism outbreak associated with home-canned peas: New York City, 2018. Morbidity and Mortality Wkly Report
68:251–252. 10.15585/mmwr.mm6810a5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.15585/mmwr.mm6810a5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Division of Select Agents and Toxins. 2021. Select agents and toxins list. https://www.selectagents.gov/sat/list.htm. Accessed 1 July 2021.</Citation>
        </Reference>
        <Reference>
          <Citation>Carroll KC, Pfaller MA, Landry ML, McAdam AJ, Patel R, Richter SS, Warnock DW. 2019. Manual of clinical microbiology, 12th ed. ASM Press, Washington, DC.</Citation>
        </Reference>
        <Reference>
          <Citation>Versalovic J. 2011. Manual of clinical microbiology, 10th ed. ASM Press, Washington, DC.</Citation>
        </Reference>
        <Reference>
          <Citation>Mills DC, Midura TF, Arnon SS. 1985. Improved selective medium for the isolation of lipase-positive Clostridium botulinum from feces of human infants. J Clin Microbiol
21:947–950. 10.1128/jcm.21.6.947-950.1985.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/jcm.21.6.947-950.1985</ArticleId>
            <ArticleId IdType="pmc">PMC271823</ArticleId>
            <ArticleId IdType="pubmed">3891773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Le Gratiet T, Poezevara T, Rouxel S, Houard E, Mazuet C, Chemaly M, Marechal CL. 2020. Development of an innovative and quick method for the isolation of Clostridium botulinum strains involved in avian botulism outbreaks. Toxins
12:42. 10.3390/toxins12010042.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/toxins12010042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pellett S, Tepp WH, Johnson EA. 2019. Critical analysis of neuronal cell and the mouse bioassay for detection of botulinum neurotoxins. Toxins
11:713. 10.3390/toxins11120713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/toxins11120713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dezfulian M, Bartlett JG. 1985. Detection of Clostridium botulinum type B toxin in the presence of a lethal substance interfering with toxin neutralization. Diagn Microbiol Infect Dis
3:105–112. 10.1016/0732-8893(85)90018-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0732-8893(85)90018-5</ArticleId>
            <ArticleId IdType="pubmed">3884243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Horwitz MA, Hatheway CL, Dowell VR. 1976. Laboratory diagnosis of botulism complicated by pyridostigmine treatment of the patient. A method for selectively removing interfering substances from clinical specimens. Am J Clin Pathol
66:737–742. 10.1093/ajcp/66.4.737.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ajcp/66.4.737</ArticleId>
            <ArticleId IdType="pubmed">970375</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilder-Kofie TD, Lúquez C, Adler M, Dykes JK, Coleman JD, Maslanka SE. 2011. An alternative in vivo method to refine the mouse bioassay for botulinum toxin detection. Comp Med
61:235–242.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3123756</ArticleId>
            <ArticleId IdType="pubmed">21819693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stern D, von Berg L, Skiba M, Dorner MB, Dorner BG. 2018. Replacing the mouse bioassay for diagnostics and potency testing of botulinum neurotoxins: progress and challenges. Berl Munch Tierarztl Wochenschr
10.2376/0005-9366-17110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2376/0005-9366-17110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pellett S, Tepp WH, Toth SI, Johnson EA. 2010. Comparison of the primary rat spinal cord cell (RSC) assay and the mouse bioassay for botulinum neurotoxin type A potency determination. J Pharmacol Toxicol Methods
61:304–310. 10.1016/j.vascn.2010.01.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vascn.2010.01.003</ArticleId>
            <ArticleId IdType="pubmed">20100585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rust A, Doran C, Hart R, Binz T, Stickings P, Sesardic D, Peden AA, Davletov B. 2017. A cell line for detection of botulinum neurotoxin type B. Front Pharmacol
8:796. 10.3389/fphar.2017.00796.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphar.2017.00796</ArticleId>
            <ArticleId IdType="pmc">PMC5684488</ArticleId>
            <ArticleId IdType="pubmed">29170639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bak N, Rajagopal S, Stickings P, Sesardic D. 2017. SiMa cells for a serotype specific and sensitive cell-based neutralization test for botulinum toxin A and E. Toxins
9:230. 10.3390/toxins9070230.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/toxins9070230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernández-Salas E, Wang J, Molina Y, Nelson JB, Jacky BP, Aoki KR. 2012. Botulinum neurotoxin serotype A specific cell-based potency assay to replace the mouse bioassay. PLoS One
7:e49516. 10.1371/journal.pone.0049516.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0049516</ArticleId>
            <ArticleId IdType="pmc">PMC3504020</ArticleId>
            <ArticleId IdType="pubmed">23185348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor K, Gericke C, Alvarez LR. 2019. Botulinum toxin testing on animals is still a Europe-wide issue. ALTEX
36:81–90. 10.14573/altex.1807101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14573/altex.1807101</ArticleId>
            <ArticleId IdType="pubmed">30303513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perry MJ, Centurioni DA, Davis SW, Hannett GE, Musser KA, Egan CT. 2017. Implementing the Bruker MALDI biotyper in the public health laboratory for C. botulinum neurotoxin detection. Toxins (Basel)
9:94. 10.3390/toxins9030094.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/toxins9030094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalb SR, Krilich JC, Dykes JK, Luquez C, Maslanka SE, Barr JR. 2015. Detection of botulinum toxins A, B, E, and F in foods by Endopep-MS. J Agric Food Chem
63:1133–1141. 10.1021/jf505482b.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/jf505482b</ArticleId>
            <ArticleId IdType="pmc">PMC4523457</ArticleId>
            <ArticleId IdType="pubmed">25578960</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalb SR, Smith TJ, Moura H, Hill K, Lou J, Geren IN, Garcia-Rodriguez C, Marks JD, Smith LA, Pirkle JL, Barr JR. 2008. The use of Endopep-MS to detect multiple subtypes of botulinum neurotoxins A, B, E, and F. Int J Mass Spectrom
278:101–108. 10.1016/j.ijms.2008.04.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijms.2008.04.004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boyer AE, Moura H, Woolfitt AR, Kalb SR, McWilliams LG, Pavlopoulos A, Schmidt JG, Ashley DL, Barr JR. 2005. From the mouse to the mass spectrometer:  detection and differentiation of the endoproteinase activities of botulinum neurotoxins A−G by mass spectrometry. Anal Chem
77:3916–3924. 10.1021/ac050485f.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/ac050485f</ArticleId>
            <ArticleId IdType="pubmed">15987092</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang D, Baudys J, Hoyt KM, Barr JR, Kalb SR. 2017. Further optimization of peptide substrate enhanced assay performance for BoNT/A detection by MALDI-TOF mass spectrometry. Anal Bioanal Chem
409:4779–4786. 10.1007/s00216-017-0421-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00216-017-0421-8</ArticleId>
            <ArticleId IdType="pmc">PMC5519644</ArticleId>
            <ArticleId IdType="pubmed">28573317</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalb SR, Baudys J, Kiernan K, Wang D, Becher F, Barr JR. 2020. Proposed BoNT/A and /B peptide substrates cannot detect multiple subtypes in the Endopep-MS assay. J Anal Toxicol
44:173–179. 10.1093/jat/bkz044.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jat/bkz044</ArticleId>
            <ArticleId IdType="pmc">PMC6949424</ArticleId>
            <ArticleId IdType="pubmed">31287544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frye EA, Egan C, Perry MJ, Crouch EE, Burbank KE, Kelly KM. 2020. Outbreak of botulism type A in dairy cows detected by MALDI-TOF mass spectrometry. J Vet Diagn Invest
32:722–726. 10.1177/1040638720943127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1040638720943127</ArticleId>
            <ArticleId IdType="pmc">PMC7488966</ArticleId>
            <ArticleId IdType="pubmed">32715936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tevell Aberg A, Karlsson I, Hedeland M. 2021. Modification and validation of the Endopep-mass spectrometry method for botulinum neurotoxin detection in liver samples with application to samples collected during animal botulism outbreaks. Anal Bioanal Chem
413:345–354. 10.1007/s00216-020-03001-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00216-020-03001-z</ArticleId>
            <ArticleId IdType="pmc">PMC7806574</ArticleId>
            <ArticleId IdType="pubmed">33119784</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalb SR, Goodnough MC, Malizio CJ, Pirkle JL, Barr JR. 2005. Detection of botulinum neurotoxin A in a spiked milk sample with subtype identification through toxin proteomics. Anal Chem
77:6140–6146. 10.1021/ac0511748.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/ac0511748</ArticleId>
            <ArticleId IdType="pubmed">16194071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kull S, Schulz KM, Weisemann J, Kirchner S, Schreiber T, Bollenbach A, Dabrowski PW, Nitsche A, Kalb SR, Dorner MB, Barr JR, Rummel A, Dorner BG. 2015. Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype. PLoS One
10:e0116381. 10.1371/journal.pone.0116381.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0116381</ArticleId>
            <ArticleId IdType="pmc">PMC4320087</ArticleId>
            <ArticleId IdType="pubmed">25658638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalb SR, Baudys J, Rees JC, Smith TJ, Smith LA, Helma CH, Hill K, Kull S, Kirchner S, Dorner MB, Dorner BG, Pirkle JL, Barr JR. 2012. De novo subtype and strain identification of botulinum neurotoxin type B through toxin proteomics. Anal Bioanal Chem
403:215–226. 10.1007/s00216-012-5767-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00216-012-5767-3</ArticleId>
            <ArticleId IdType="pmc">PMC3309144</ArticleId>
            <ArticleId IdType="pubmed">22395449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharma SK, Ferreira JL, Eblen BS, Whiting RC. 2006. Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies. Appl Environ Microbiol
72:1231–1238. 10.1128/AEM.72.2.1231-1238.2006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AEM.72.2.1231-1238.2006</ArticleId>
            <ArticleId IdType="pmc">PMC1392902</ArticleId>
            <ArticleId IdType="pubmed">16461671</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Worbs S, Fiebig U, Zeleny R, Schimmel H, Rummel A, Luginbühl W, Dorner BG. 2015. Qualitative and quantitative detection of botulinum neurotoxins from complex matrices: results of the first international proficiency test. Toxins (Basel)
7:4935–4966. 10.3390/toxins7124857.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/toxins7124857</ArticleId>
            <ArticleId IdType="pmc">PMC4690107</ArticleId>
            <ArticleId IdType="pubmed">26703724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hobbs RJ, Thomas CA, Halliwell J, Gwenin CD. 2019. Rapid detection of botulinum neurotoxins: a review. Toxins
11:418. 10.3390/toxins11070418.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/toxins11070418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thirunavukkarasu N, Johnson E, Pillai S, Hodge D, Stanker L, Wentz T, Singh B, Venkateswaran K, McNutt P, Adler M, Brown E, Hammack T, Burr D, Sharma S. 2018. Botulinum neurotoxin detection methods for public health response and surveillance. Front Bioeng Biotechnol
6:80. 10.3389/fbioe.2018.00080.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fbioe.2018.00080</ArticleId>
            <ArticleId IdType="pmc">PMC6024544</ArticleId>
            <ArticleId IdType="pubmed">29988463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu J, Gao S, Kang L, Ji B, Xin W, Kang J, Li P, Gao J, Wang H, Wang J, Yang H. 2017. An ultrasensitive gold nanoparticle-based lateral flow test for the detection of active botulinum neurotoxin type A. Nanoscale Res Lett
12:227. 10.1186/s11671-017-1944-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s11671-017-1944-9</ArticleId>
            <ArticleId IdType="pmc">PMC5371539</ArticleId>
            <ArticleId IdType="pubmed">28359137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pellett S, Tepp WH, Johnson EA, Sesardic D. 2017. Assessment of ELISA as endpoint in neuronal cell-based assay for BoNT detection using hiPSC derived neurons. J Pharmacol Toxicol Methods
88:1–6. 10.1016/j.vascn.2017.04.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vascn.2017.04.013</ArticleId>
            <ArticleId IdType="pmc">PMC5623611</ArticleId>
            <ArticleId IdType="pubmed">28465161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pöhlmann C, Elßner T. 2020. Multiplex immunoassay techniques for on-site detection of security sensitive toxins. Toxins (Basel)
12:727. 10.3390/toxins12110727.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/toxins12110727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rajkovic A, El Moualij B, Fikri Y, Dierick K, Zorzi W, Heinen E, Uner A, Uyttendaele M. 2012. Detection of Clostridium botulinum neurotoxins A and B in milk by ELISA and immuno-PCR at higher sensitivity than mouse bio-assay. Food Anal Methods
5:319–326. 10.1007/s12161-011-9300-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12161-011-9300-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chao HY, Wang YC, Tang SS, Liu HW. 2004. A highly sensitive immuno-polymerase chain reaction assay for Clostridium botulinum neurotoxin type A. Toxicon
43:27–34. 10.1016/j.toxicon.2003.10.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.toxicon.2003.10.013</ArticleId>
            <ArticleId IdType="pubmed">15037026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koh CY, Schaff UY, Piccini ME, Stanker LH, Cheng LW, Ravichandran E, Singh BR, Sommer GJ, Singh AK. 2015. Centrifugal microfluidic platform for ultrasensitive detection of botulinum toxin. Anal Chem
87:922–928. 10.1021/ac504054u.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/ac504054u</ArticleId>
            <ArticleId IdType="pmc">PMC4303339</ArticleId>
            <ArticleId IdType="pubmed">25521812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davis SW, Kelly-Cirino C, Cirino N, Hannett GE, Musser KA, Egan C. 2016. A 10 year analysis of the use of multiplex real-time PCR screening for botulinum neurotoxin-producing Clostridium species. J Bacteriol Mycol
3:1030.</Citation>
        </Reference>
        <Reference>
          <Citation>Kirchner S, Krämer KM, Schulze M, Pauly D, Jacob D, Gessler F, Nitsche A, Dorner BG, Dorner MB. 2010. Pentaplexed quantitative real-time PCR assay for the simultaneous detection and quantification of botulinum neurotoxin-producing clostridia in food and clinical samples. Appl Environ Microbiol
76:4387–4395. 10.1128/AEM.02490-09.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AEM.02490-09</ArticleId>
            <ArticleId IdType="pmc">PMC2897425</ArticleId>
            <ArticleId IdType="pubmed">20435756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>CDC. 2013. Botulism associated with home-fermented tofu in two Chinese immigrants: New York City, March-April 2012. MMWR Morb Mortal Wkly Rep
62:529–532.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4604781</ArticleId>
            <ArticleId IdType="pubmed">23820965</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mitchell WG, Tseng-Ong L. 2005. Catastrophic presentation of infant botulism may obscure or delay diagnosis. Pediatrics
116:e436-8. 10.1542/peds.2005-0297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/peds.2005-0297</ArticleId>
            <ArticleId IdType="pubmed">16140690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Filozov A, Kattan JA, Jitendranath L, Smith CG, Luquez C, Phan QN, Fagan RP. 2012. Asymmetric type F botulism with cranial nerve demyelination. Emerg Infect Dis
18:102–104. 10.3201/eid1801.110471.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid1801.110471</ArticleId>
            <ArticleId IdType="pmc">PMC3310096</ArticleId>
            <ArticleId IdType="pubmed">22257488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williamson CHD, Vazquez AJ, Hill K, Smith TJ, Nottingham R, Stone NE, Sobek CJ, Cocking JH, Fernandez RA, Caballero PA, Leiser OP, Keim P, Sahl JW. 2017. Differentiating botulinum neurotoxin-producing clostridia with a simple, multiplex PCR assay. Appl Environ Microbiol
83:e00806-17. 10.1128/AEM.00806-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AEM.00806-17</ArticleId>
            <ArticleId IdType="pmc">PMC5583490</ArticleId>
            <ArticleId IdType="pubmed">28733282</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Halpin JL, Joseph L, Dykes JK, McCroskey L, Smith E, Toney D, Stroika S, Hise K, Maslanka S, Luquez C. 2017. Pulsotype diversity of Clostridium botulinum strains containing serotypes A and/or B genes. Foodborne Pathog Dis
14:494–501. 10.1089/fpd.2017.2280.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/fpd.2017.2280</ArticleId>
            <ArticleId IdType="pmc">PMC5591077</ArticleId>
            <ArticleId IdType="pubmed">28692343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jacobson MJ, Lin G, Whittam TS, Johnson EA. 2008. Phylogenetic analysis of Clostridium botulinum type A by multi-locus sequence typing. Microbiology (Reading)
154:2408–2415. 10.1099/mic.0.2008/016915-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/mic.0.2008/016915-0</ArticleId>
            <ArticleId IdType="pmc">PMC2562668</ArticleId>
            <ArticleId IdType="pubmed">18667573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maiden MC, Jansen van Rensburg MJ, Bray JE, Earle SG, Ford SA, Jolley KA, McCarthy ND. 2013. MLST revisited: the gene-by-gene approach to bacterial genomics. Nat Rev Microbiol
11:728–736. 10.1038/nrmicro3093.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrmicro3093</ArticleId>
            <ArticleId IdType="pmc">PMC3980634</ArticleId>
            <ArticleId IdType="pubmed">23979428</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosen HE, Kimura AC, Crandall J, Poe A, Nash J, Boetzer J, Tecle S, Mukhopadhyay R, McAuley K, Kasirye O, Garza A, Shahkarami M, Chaturvedi V, Kiang D, Vidanes J, McCoy K, Barcellos M, Derby T, Jain S, Vugia DJ. 2020. Foodborne botulism outbreak associated with commercial nacho cheese sauce from a gas station market. Clin Infect Dis
70:1695–1700. 10.1093/cid/ciz479.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/ciz479</ArticleId>
            <ArticleId IdType="pubmed">31247064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Halpin JL, Dykes JK, Katz L, Centurioni DA, Perry MJ, Egan CT, Luquez C. 2019. Molecular characterization of Clostridium botulinum harboring the bont/B7 gene. Foodborne Pathog Dis
16:428–433. 10.1089/fpd.2018.2600.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/fpd.2018.2600</ArticleId>
            <ArticleId IdType="pmc">PMC6585170</ArticleId>
            <ArticleId IdType="pubmed">30932710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gonzalez-Escalona N, Sharma SK. 2020. Closing Clostridium botulinum group I genomes using a combination of short- and long-reads. Front Microbiol
11:239. 10.3389/fmicb.2020.00239.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2020.00239</ArticleId>
            <ArticleId IdType="pmc">PMC7050642</ArticleId>
            <ArticleId IdType="pubmed">32153532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gonzalez-Escalona N, Timme R, Raphael BH, Zink D, Sharma SK. 2014. Whole-genome single-nucleotide-polymorphism analysis for discrimination of Clostridium botulinum group I strains. Appl Environ Microbiol
80:2125–2132. 10.1128/AEM.03934-13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AEM.03934-13</ArticleId>
            <ArticleId IdType="pmc">PMC3993156</ArticleId>
            <ArticleId IdType="pubmed">24463972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raphael BH, Shirey TB, Lúquez C, Maslanka SE. 2014. Distinguishing highly-related outbreak-associated Clostridium botulinum type A(B) strains. BMC Microbiol
14:192. 10.1186/1471-2180-14-192.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2180-14-192</ArticleId>
            <ArticleId IdType="pmc">PMC4112988</ArticleId>
            <ArticleId IdType="pubmed">25031122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Halliwell J, Savage AC, Buckley N, Gwenin C. 2014. Electrochemical impedance spectroscopy biosensor for detection of active botulinum neurotoxin. Sens Biosensing Res
2:12–15. 10.1016/j.sbsr.2014.08.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.sbsr.2014.08.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Montana V, Grubisic V, Stout RF Jr, Parpura V, Gu LQ. 2015. Nanopore sensing of botulinum toxin type B by discriminating an enzymatically cleaved peptide from a synaptic protein synaptobrevin 2 derivative. ACS Appl Mater Interfaces
7:184–192. 10.1021/am5056596.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/am5056596</ArticleId>
            <ArticleId IdType="pmc">PMC4296922</ArticleId>
            <ArticleId IdType="pubmed">25511125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Fry HC, Skinner GE, Schill KM, Duncan TV. 2017. Detection and quantification of biologically active botulinum neurotoxin serotypes A and B using a Forster resonance energy transfer-based quantum dot nanobiosensor. ACS Appl Mater Interfaces
9:31446–31457. 10.1021/acsami.7b08736.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acsami.7b08736</ArticleId>
            <ArticleId IdType="pubmed">28840718</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Schill KM, Fry HC, Duncan TV. 2020. A quantum dot nanobiosensor for rapid detection of botulinum neurotoxin serotype E. ACS Sens
5:2118–2127. 10.1021/acssensors.0c00738.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acssensors.0c00738</ArticleId>
            <ArticleId IdType="pubmed">32527082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ambrin G, Kumar R, Singh BR. 2018. Differential endopeptidase activity of different forms of type A botulinum neurotoxin: a unique relationship between the size of the substrate and activity of the enzyme. Toxicon
144:34–41. 10.1016/j.toxicon.2017.12.055.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.toxicon.2017.12.055</ArticleId>
            <ArticleId IdType="pubmed">29309744</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barr JR, Moura H, Boyer AE, Woolfitt AR, Kalb SR, Pavlopoulos A, McWilliams LG, Schmidt JG, Martinez RA, Ashley DL. 2005. Botulinum neurotoxin detection and differentiation by mass spectrometry. Emerg Infect Dis
11:1578–1583. 10.3201/eid1110.041279.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid1110.041279</ArticleId>
            <ArticleId IdType="pmc">PMC3366733</ArticleId>
            <ArticleId IdType="pubmed">16318699</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang D, Baudys J, Ye Y, Rees JC, Barr JR, Pirkle JL, Kalb SR. 2013. Improved detection of botulinum neurotoxin serotype A by Endopep-MS through peptide substrate modification. Anal Biochem
432:115–123. 10.1016/j.ab.2012.09.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ab.2012.09.021</ArticleId>
            <ArticleId IdType="pmc">PMC4618377</ArticleId>
            <ArticleId IdType="pubmed">23017875</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
